By the time your brain registers "I'm full," you've already eaten too much
Self-adjusting doses without medical guidance is risky, and if the medication is not actually degraded, you could end up with a dose that causes excessive gastrointestinal side effects , dizziness , or excessive burping and nausea
While both fall under the umbrella of "incretin mimetics," their unique biological actions can produce very different outcomes
Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work